A company does not die all at once. It dies in stages, in a sequence so consistent that once you have seen it, you can set your watch by it.

The Vulture has performed this autopsy enough times to name every stage before it arrives.

Stage one is the debt. It rarely looks like danger at the start. The company takes on borrowing—to grow, to buy back stock, to fund an acquisition, or because a new owner loaded it on. The balance sheet still looks fine. The interest is affordable. Everyone is relaxed. This is the stage where the cause of death is introduced and almost no one notices.

Stage two is the squeeze. Conditions shift. Sales soften, or rates rise, or a category moves on without them. Suddenly the debt that was affordable is merely sustainable. Cash that used to fund the future now funds the past. Reinvestment quietly stops. The company is still standing, still profitable on paper, but it has begun to eat itself.

Stage three is vendor flight. This is the one outsiders miss and insiders fear most. Suppliers, sensing risk, start asking for cash up front instead of offering terms. The company's own partners are now betting against it. Working capital tightens like a noose. By the time this shows up in a headline, the people closest to the business have already voted with their invoices.

Stage four is the liquidity lie. Leadership insists everything is fine — right up until it files a document admitting it is not. The gap between the public message and the private reality is never wider than in this stage. Confidence is performed precisely because it has run out.

Stage five is the filing. The autopsy the world finally gets to see. But by now the death was old news to anyone who watched stages one through four.

The collapse is never the surprise. The collapse is just the part that makes the news.

— The Vulture

For educational purposes only. Not financial advice.